調査レポートカテゴリー： MarketsandMarkets, 世界, 医療/バイオ

Metabolomics (Biomarker Discovery/Metabolite Detection/Metabolite Profiling) Market By Applications (Drug Discovery/Toxicology Assessment/ Diagnosis) and Indications (Oncology/Cardiology/Neurology) - Forecasts from 2012 to 2017

世界のメタボロミクス（バイオマーカー発見/代謝物検知/代謝物プロファイル）市場

◆タイトル：Metabolomics (Biomarker Discovery/Metabolite Detection/Metabolite Profiling) Market By Applications (Drug Discovery/Toxicology Assessment/ Diagnosis) and Indications (Oncology/Cardiology/Neurology) - Forecasts from 2012 to 2017
◆商品コード：MD 1360
◆調査・発行会社：MarketsandMarkets
◆発行日：2013年1月
◆ページ数：136
◆レポート形式：pdf / 英語
◆納品方法：Eメール
◆調査対象地域：グローバル
◆販売価格オプション（消費税別）
Single userUSD5,650 ⇒換算￥621,500見積依頼/購入/質問フォーム
Multi User（～5名まで）USD6,650 ⇒換算￥731,500見積依頼/購入/質問フォーム
Corporate licence（社内共有可）USD8,150 ⇒換算￥896,500見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※商品の納品後、納品日＋5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。（振込先：三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※ご購入後、レポートに記載の英語表現や単語の意味に関しましては無料でお答えいたします。（但し、対応範囲は弊社で判断）
※弊社H&Iグローバルリサーチ株式会社はMarketsandMarketsの日本における正規販売代理店です。

 【レポートの概要】

本調査レポートでは、"世界のメタボロミクス（バイオマーカー発見/代謝物検知/代謝物プロファイル）市場"について調査・分析し、イントロダクション、エグゼクティブサマリー、市場の成長要因、阻害要因、市場の機会と課題、バリューチェーン分析、投資機会、市場の動態、市場規模及び予測、競争状況、主要企業（ベンダー）分析等の情報をお届けいたします。

Over the last decade, genomics and proteomics have been used as key tools to discover potential drug targets and to better understand the complexities of biology. To balance research in these areas, metabolomics, a new science is evolving for analyzing the basic metabolic changes taking place in a living organism. Metabolomics is thus an emerging concept which refers to the systematic study of the distinctive chemical fingerprints generated in a particular cellular process.

Metabolomics Market – Analysis of Global Technology, Application Trends and Landscape 2012-2017 report covers the market by disease indications along with the applications and metabolite profiling for biomarker discovery applications. In addition, it also includes the factors driving and restraining the market and covers the market scenario in the U.S., Europe, Asia and the Rest of the World (ROW). This report will provide the company profiles of key companies along with the competitive analysis.

The Global Metabolomics market is showing a double digit growth (CAGR 35%) due to supportive factors such as, (i) increased willingness of biotechnology and pharma companies to adopt metabolomics concept to drive R&D activity within the industry, (ii) rapid growth of metabolomics data analysis softwares and solutions, and (iii) the advancement of analytical technologies. Metabolomics is used in the identification of new biomarkers, which indicate a change in the physiological state of a cell or tissue. Biomarker screening is important in the process of new drug discovery, and is also a key in vitro diagnostics tool. Additionally it is also being used for environmental toxicology screening. While, there are major concerns of this market such as the validation challenges, the positive aspects may very well offset the market restraints to aid the market grow at an exceptional rate.

The report also profiles leading participants of this industry with their recent developments and other strategic industry activities. These include: Metabolon Inc (U.S.), Metanomics (Germany), Metabolomic Technologies Inc. (U.S.), Human Metabolome Technologies (Japan), Beckman Coulter (U.S.), Agilent Technologies Inc (U.S.), Bruker Corporation (U.S.), Waters Corporation (U.S.), Biocrates Lifesciences (Austria), Chenomx Inc (Canada), Eisai co. ltd (Japan), Nextgen Metabolomics (U.S.), Phenomenome Discoveries Inc. (Canada) and Metabolomic Discoveries (Germany).

Scope of the Report

This technology report categorizes the market for metabolomics by geographical region (including the important countries in each region), applications, and indications, forecasting the market value in revenue by analyzing the trends in detection instruments and separation techniques (E.g. HPLC, Capillary Electrophoresis).
A detailed description of global technological developments and evolving trends in the field of metabolomics with key prominence on product innovations by industries and collaborative efforts by the academic research institutions.
A comprehensive picture of different types of detection instruments available for metabolite analysis (e.g. Mass Spectrometry, NMR, Electrochemical detection and Ion mobility spectrometer), prioritized based on critical criterias through Analytical Hierarchy Process (AHP).
An impact analysis of major drivers, restraints and challenges influencing the adoption and growth of metabolomics market during the forecast period from 2012 to 2017.
Market size – Global market forecast for the next 5 years from 2012 – 2017 by including demand side analysis and strategic recommendations for technology/product developers.
Competitive landscape based on the analysis of key patents and research publications that gives an insight into prominent activities and global participants.

【レポートの目次】

TABLE OF CONTENTS

1 INTRODUCTION
1.1 KEY TAKE-AWAYS
1.2 REPORT SCOPE
1.3 RESEARCH METHODOLOGY
1.4 KEY DATA POINTS FROM SECONDARY SOURCES

2 EXECUTIVE SUMMARY

3 METABOLOMICS –TECHNOLOGY LANDSCAPE ANALYSIS
3.1 INTRODUCTION
3.2 METABOLOMICS AND METABONOMICS
3.3 SEPARATION TECHNIQUES – HIGH PERFORMANCE LIQUID CHROMATOGRAPHY (HPLC)
3.4 SEPARATION TECHNIQUES – CAPILLARY ELECTROPHORESIS (CE)
3.5 DETECTION TECHNIQUES – MASS SPECTROMETRY (MS)
3.6 DETECTION TECHNIQUES – NUCLEAR MAGNETIC RESONANCE (NMR)
3.7 DETECTION TECHNIQUES – SURFACE BASED MASS ANALYSIS
3.8 KEY APPLICATION AREAS
3.8.1 BIOMARKER DISCOVERY
3.8.2 DRUG DISCOVERY
3.8.3 TOXICITY ASSESSMENT/TOXICOLOGY
3.8.4 NUTRI-GENOMICS
3.9 CONCEPTUAL APPROACH
3.9.1 TARGET ANALYSIS
3.9.2 METABOLITE PROFILING
3.9.3 METABOLITE FINGERPRINTING
3.10 TECHNOLOGY TRENDS IN METABOLOMICS
3.11 VALUE CHAIN ANALYSIS

4 METABOLOMICS – MARKET LANDSCAPE ANALYSIS
4.1 GLOBAL METABOLOMICS MARKET SEGMENTATION
4.2 MARKET FORECAST
4.2.1 GLOBAL METABOLOMICS MARKET REVENUE FORECAST – INTRODUCTION
4.2.2 GLOBAL METABOLOMICS MARKET REVENUE – REGIONAL
4.2.3 GLOBAL METABOLOMICS MARKET REVENUE – INDICATION
4.2.4 GLOBAL METABOLOMICS MARKET REVENUE, BY APPLICATION
4.3 MARKET DYNAMICS
4.3.1 DRIVERS
4.3.2 RESTRAINTS
4.3.3 CHALLENGES
4.3.4 EMERGING TRENDS
4.4 DEMAND SIDE ANALYSIS

5 METABOLOMICS – TECHNOLOGY INVESTMENT POTENTIAL 70-81
5.1 INVESTMENT CLIMATE ASSESSMENT
5.1.1 INVESTMENT CLIENT NETWORKS
5.1.1.1 FUNDING BODIES
5.1.1.2 INSIGHTS ON CURRENT & FUTURE TECH-INVESTMENT TREND
5.1.2 FUNDING OPPORTUNITIES
5.1.3 ANALYSIS OF POTENTIAL AREAS FOR TECHNOLOGY INVESTMENT USING STRATEGIC EVALUATION

6 METABOLOMICS – GEOGRAPHICAL ANALYSIS
6.1 INTRODUCTION
6.2 U.S., CANADA, MEXICO
6.3 EUROPE
6.4 ASIA & REST OF THE WORLD (ROW)

7 COMPETITIVE LANDSCAPE ANALYSIS
7.1 MERGERS & ACQUISITIONS
7.2 NEW PRODUCT DEVELOPMENTS
7.3 COLLABORATIONS

8 PATENT ANALYSIS
8.1 PATENT ANALYSIS

9 TECHNOLOGY ANALYSIS (USING MULTI CRITERIA DECISION MAKING) & ROAD MAPPING 94-100
9.1 LEVEL 0 CRITERIA DESCRIPTION
9.2 COMPARISON OF DEVICES BASED ON LEVEL 0 CRITERIA
9.3 TECHNOLOGY PRIORITIZATION AND AHP ANALYSIS FINDINGS
9.4 TECHNOLOGY ROADMAP

10 ANALYST INSIGHTS & RECOMMENDATIONS
10.1 ANALYST INSIGHTS
10.2 STRATEGIC RECOMMENDATIONS FOR TECHNOLOGY & BUSINESS MANAGEMENT

11 COMPANY PROFILES
11.1 AGILENT TECHNOLOGIES
11.2 BRUKER CORPORATION
11.3 METABOLOMIC TECHNOLOGIES
11.4 METABOLON
11.5 CHENOMX
11.6 BIO-RAD LABORATORIES
11.7 WATERS CORPORATION
11.8 HUMAN METABOLOME TECHNOLOGIES
11.9 NEXTGEN METABOLOMICS
11.10 BIOCRATES LIFE SCIENCES AG
11.11 STEMINA BIOMARKER
11.12 PHENOMENOME
11.13 METANOMICS GMBH
11.14 ACCELRYS
11.15 EISAI CO. LTD.
11.16 SHIMADZU CORPORATION
11.17 SIDMAP, LLC
11.18 ASTRAZENECA PLC
11.19 AB SCIEX
11.2 METABOLOMX
11.21 RESEARCH INSTITUTE OF CHROMATOGRAPHY (RIC)

12 APPENDIX
12.1 KEY PATENTS

13 GLOSSARY

LIST OF TABLES

TABLE 1 GLOBAL METABOLOMICS MARKET REVENUE, BY REGIONAL ($MILLION)
TABLE 2 GLOBAL METABOLOMICS MARKET REVENUE, BY INDICATION ($MILLION)
TABLE 3 GLOBAL METABOLOMICS MARKET REVENUE ($MILLION), Y-O-Y GROWTH (%), BY ONCOLOGY INDICATION
TABLE 4 GLOBAL METABOLOMICS MARKET REVENUE ($MILLION), Y-O-Y GROWTH (%), BY CARDIOLOGY INDICATION
TABLE 5 GLOBAL METABOLOMICS MARKET REVENUE ($MILLION), Y-O-Y GROWTH (%), BY NEUROLOGY INDICATION
TABLE 6 GLOBAL METABOLOMICS MARKET REVENUE ($MILLION), Y-O-Y GROWTH (%), BY OTHER INDICATIONS
TABLE 7 GLOBAL METABOLOMICS MARKET REVENUE, BY APPLICATION ($MILLION)
TABLE 8 GLOBAL METABOLOMICS MARKET REVENUE ($MILLION), Y-O-Y GROWTH (%), BY BIO MARKER DISCOVERY APPLICATION
TABLE 9 GLOBAL METABOLOMICS MARKET REVENUE ($MILLION), Y-O-Y GROWTH (%), BY DRUG DISCOVERY APPLICATION
TABLE 10 GLOBAL METABOLOMICS MARKET REVENUE ($MILLION), Y-O-Y GROWTH (%), BY TOXICOLOGY TESTING APPLICATION
TABLE 11 GLOBAL METABOLOMICS MARKET REVENUE ($MILLION), Y-O-Y GROWTH (%), BY OTHER APPLICATIONS

LIST OF OTHER TABLES

TABLE 1 MARKET DYNAMICS-DRIVERS IMPACT BY TIMELINE
TABLE 2 MARKET DYNAMICS-RESTRAINTS IMPACT BY TIMELINE
TABLE 3 OPPORTUNITY STRATEGIC EVALUATION ANALYSIS
TABLE 4 MERGERS AND ACQUISITIONS
TABLE 5 NEW PRODUCT DEVELOPMENTS
TABLE 6 COLLABORATIONS
TABLE 7 KEY PATENTS

LIST OF FIGURES

FIG 1 RESEARCH METHODOLOGY
FIG 2 GLOBAL METABOLOMICS MARKET REVENUE, 2012 - 2017 ($MILLION)
FIG 3 MARKET SHARE BY REGION, 2012 - 2017 (%)
FIG 4 KEY APPLICATION AREAS
FIG 5 FLOW CHART OF NUTRI-GENOMICS
FIG 6 CONCEPTUAL APPROACH
FIG 7 VALUE CHAIN ANALYSIS
FIG 8 PERCENTAGE OF STAKE HOLDERS IN METABOLOMICS VALUE CHAIN
FIG 9 GLOBAL METABOLOMICS MARKET SEGMENTATION
FIG 10 GLOBAL METABOLOMICS MARKET REVENUE FORECAST, 2012 - 2017 ($MILLION)
FIG 11 GLOBAL METABOLOMICS MARKET REVENUE, BY REGIONAL ($MILLION)
FIG 12 GLOBAL METABOLOMICS MARKET Y-O-Y GROWTH RATE, BY REGION
FIG 13 MARKET SHARE, BY REGION, 2012 - 2017 (%)
FIG 14 GLOBAL METABOLOMICS MARKET REVENUE, BY INDICATION ($MILLION)
FIG 15 GLOBAL METABOLOMICS MARKET REVENUE ($MILLION), Y-O-Y GROWTH (%), BY ONCOLOGY INDICATION
FIG 16 GLOBAL METABOLOMICS MARKET REVENUE ($MILLION), Y-O-Y GROWTH (%), BY CARDIOLOGY INDICATION
FIG 17 GLOBAL METABOLOMICS MARKET REVENUE ($MILLION), Y-O-Y GROWTH (%), BY NEUROLOGY INDICATION
FIG 18 GLOBAL METABOLOMICS MARKET REVENUE ($MILLION), Y-O-Y GROWTH (%), BY OTHER INDICATIONS
FIG 19 GLOBAL MARKET SHARE, BY INDICATION, 2012 - 2017 (%)
FIG 20 GLOBAL METABOLOMICS MARKET REVENUE, BY APPLICATION ($MILLION)
FIG 21 GLOBAL METABOLOMICS MARKET REVENUE ($MILLION), Y-O-Y GROWTH (%), BY BIO MARKER DISCOVERY APPLICATION
FIG 22 GLOBAL METABOLOMICS MARKET REVENUE ($MILLION), Y-O-Y GROWTH (%), BY DRUG DISCOVERY APPLICATION
FIG 23 GLOBAL METABOLOMICS MARKET REVENUE ($MILLION), Y-O-Y GROWTH (%), BY TOXICOLOGY TESTING APPLICATION
FIG 24 GLOBAL METABOLOMICS MARKET REVENUE ($MILLION), Y-O-Y GROWTH (%), BY OTHER APPLICATIONS
FIG 25 GLOBAL PERCENTAGE DISTRIBUTION OF METABOLOMICS MARKET, BY APPLICATIONS, 2012 - 2017 (%)
FIG 26 DEMAND SIDE ANALYSIS
FIG 27 INVESTMENT CLIENT NETWORKS
FIG 28 OPPORTUNITY STRATEGIC EVALUATION ANALYSIS
FIG 29 REGIONS WITH HIGH TECHNOLOGY ADOPTION
FIG 30 PATENT DISTRIBUTION AMONG TOP PLAYERS
FIG 31 AHP ANALYSIS
FIG 32 PRIORITY VALUES
FIG 33 COMPARISON OF DEVICES BASED ON LEVEL 0 CRITERIA
FIG 34 TECHNOLOGY PRIORITIZATION AND AHP ANALYSIS FINDINGS
FIG 35 TECHNOLOGY ROADMAP
FIG 36 STRATEGIC RECOMMENDATIONS FOR TECHNOLOGY & BUSINESS MANAGEMENT

★調査レポート[世界のメタボロミクス（バイオマーカー発見/代謝物検知/代謝物プロファイル）市場] ( Metabolomics (Biomarker Discovery/Metabolite Detection/Metabolite Profiling) Market By Applications (Drug Discovery/Toxicology Assessment/ Diagnosis) and Indications (Oncology/Cardiology/Neurology) - Forecasts from 2012 to 2017 / MD 1360) 販売に関する免責事項
[世界のメタボロミクス（バイオマーカー発見/代謝物検知/代謝物プロファイル）市場] ( Metabolomics (Biomarker Discovery/Metabolite Detection/Metabolite Profiling) Market By Applications (Drug Discovery/Toxicology Assessment/ Diagnosis) and Indications (Oncology/Cardiology/Neurology) - Forecasts from 2012 to 2017 / MD 1360) についてEメールでお問い合わせ
◆関連調査資料◆
  • がん用バイオマーカーの世界市場予測（～2022年）：タンパク質バイオマーカー、遺伝子バイオマーカー
    MAM-MD-5627 / MarketsandMarkets / 2017年10月5日 / MarketsandMarketsが発行した当調査レポートでは、がん用バイオマーカーの世界市場について調査・分析し、エグゼクティブサマリー、市場インサイト、市場概観/市場動向、市場シェア分析、種類別分析、がんタイプ別分析、技術別分析、用途別分析、がん用バイオマーカーの世界市場規模及び予測、市場動向、競争状況、関連企業分析などの情報をお届けいたします。...The global cancer biomarkers market is projected to reach USD 20.48 billion by 2022 from USD 11.53 billion in 2017, at a CAGR of 12.2% from 2017 to 2022. Over the years, the cancer biomarkers market has evolved significantly owing to the rising prevalence of cancer, advancements in omics technologies, increasing healthcare expenditure, growth in R&D funding from government and private bodies, and rising demand for personalized medicine in cancer therapies. However, an unfavorable regulatory and reimbursement scenario and the high capital investments required for biomarker development and validation are some factors expected to restrain the market. The cancer biomarkers...
  • マルチプレックスアッセイの世界市場予測（～2023年）
    BT-4473 / MarketsandMarkets / 2018年6月7日 / MarketsandMarketsが発行した当調査レポートでは、マルチプレックスアッセイの世界市場について調査・分析し、エグゼクティブサマリー、市場インサイト、市場概観/市場動向、製品（消耗品、装置）別分析、種類別分析、技術別分析、用途（研究開発、診断）別分析、マルチプレックスアッセイの世界市場規模及び予測、市場動向、競争状況、関連企業分析などの情報をお届けいたします。...The global multiplex assays market is projected to reach USD 3.35 Billion in 2023 from USD 2.33 Billion in 2018, at CAGR of 7.5%. Multiplex assays enables the simultaneous detection of multiple analytes in a single run/cycle of the assay. The use of multiplex assays in companion diagnostics for increasing the safety & efficacy of therapies and the advantages of multiplex assays over conventional singleplex assays are driving the growth of the market. In this report, the market has been categorized based on product & service, type, technology, application, and end user. Based on product and service, the multiplex assays...
  • ヒト肝臓モデルの世界市場予測（～2022年）
    BT6218 / MarketsandMarkets / 2018年4月26日 / 当調査レポートでは、ヒト肝臓モデルの世界市場について調査・分析し、エグゼクティブサマリー、市場インサイト、市場概観/市場動向、創薬プラットフォーム別分析、地域別分析、ヒト肝臓モデルの世界市場規模及び予測、市場動向、競争状況、関連企業分析などの情報をお届けいたします。...The global human liver models market is projected to reach USD 2.56 Billion by 2022 from USD 1.35 Billion in 2017, at a CAGR of 13.6%. The growth of this market is primarily driven by factors such as the growing focus on developing alternatives for animal testing models, significant increase in research funding and venture capital investments for the development of liver models, growing initiatives to increase awareness about liver organoids, increasing research activities on liver organoids, increasing prevalence of non-alcoholic fatty liver disease, and growing need for the early detection of drug toxicity to minimize financial losses due to...
  • ラベルフリー検出の世界市場予測（～2022年）：技術（表面プラズモン共鳴法、バイオレイヤー干渉法）、製品、用途、エンドユーザー
    BT-2455 / MarketsandMarkets / 2017年10月11日 / MarketsandMarketsが発行した当調査レポートでは、ラベルフリー検出の世界市場について調査・分析し、エグゼクティブサマリー、市場インサイト、市場概観/市場動向、市場シェア分析、技術別分析、製品別分析、用途別分析、需要先別分析、ラベルフリー検出の世界市場規模及び予測、市場動向、競争状況、関連企業分析などの情報をお届けいたします。...The global label-free detection market is expected to reach USD 1,311.2 Million by 2022 from USD 872.0 Million in 2017, at a CAGR of 8.5%. A number of factors such as increasing number of genomics research activities for studying diseases, advances in label-free detection techniques, growing awareness and demand for use of biosensors in biomolecular interaction studies, and increasing expenditure on drug discovery and development by private and public organizations are expected to drive the growth of this market. The global label-free detection market is segmented by product, technology, application, end user, and region. By product, the market is segmented...
  • デジタルPCR及びリアルタイムPCR（qPCR）の世界市場予測（～2022年）：装置、試薬
    MAM-BT3161 / MarketsandMarkets / 2017年6月27日 / 当調査レポートでは、デジタルPCR及びリアルタイムPCR（qPCR）の世界市場について調査・分析し、エグゼクティブサマリー、市場インサイト、市場概観/市場動向、産業動向、バリューチェーン分析、市場シェア分析、市場環境分析、技術別分析、製品別分析、用途別分析、需要先別分析、デジタルPCR及びリアルタイムPCR（qPCR）の世界市場規模及び予測、市場動向、競争状況、関連企業分析などの情報をお届けいたします。...The global dPCR and qPCR market is expected to reach USD 5.31 Billion by 2022, growing at a CAGR of 8.9% during 2017-2022. Factors such as the growth in the geriatric population, rising incidence of infectious diseases and genetic disorders, technological advancements in the field of PCR, and increasing investments and availability of funds for PCR-based research are driving the growth of the global dPCR and qPCR market. However, factors such as high cost of dPCR products and technical limitations associated with qPCR and dPCR are restraining the growth of this market. In addition to this, adoption and implementation of...

    • ◆H&Iグローバルリサーチ株式会社のお客様（例）◆